Humanigen Inc (HGENQ)

[Corundum]

According to the February 8 announcement, Chappell is still CSO, as well as becoming a director:

"Humanigen, Inc. (NASDAQ:HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called cytokine storm with its lead drug candidate lenzilumab™, today announced that the Company’s Board of Directors (the “Board”) has elected Dr. Dale Chappell, the Company’s chief scientific officer, to serve as a director of the Company, effective February 5, 2021. Dr. Chappell will continue to serve as the Company’s chief scientific officer."

Has something changed since then?